Benitec Biopharma Inc. (NASDAQ:BNTC) Receives $24.43 Average Price Target from Brokerages
Shares of Benitec Biopharma Inc. (NASDAQ:BNTC – Get Free Report) have received a consensus rating of “Buy” from the nine analysts that are covering the stock, MarketBeat.com reports. Seven analysts have rated the stock with a buy recommendation and two have given a strong buy recommendation to the company. The average 12 month target price […]
Shares of Benitec Biopharma Inc. (NASDAQ:BNTC – Get Free Report) have received a consensus rating of “Buy” from the nine analysts that are covering the stock, MarketBeat.com reports. Seven analysts have rated the stock with a buy recommendation and two have given a strong buy recommendation to the company. The average 12 month target price […]
